Skip to content
GLP-1 Savers
Menu
Ranked #74 · Fair Price

Maves review

Maves, operating under parent company Homera Health, is a performance-framed telehealth platform offering compounded semaglutide and tirzepatide for weight loss plus sermorelin for anti-aging.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $99/mo

Save ~93% vs brand-name

From $99/mo (starting dose, first-month rate, compounded)

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The published figure is a starting rate, not a price that is guaranteed at every dose.

How much does Maves cost?

The price Maves publishes is From $99/mo (starting dose, first-month rate, compounded). We flag this one to watch: confirm the ongoing rate with Maves before you count on it, because a low first month can step up afterward. That works out about 93% under our ~$1,349/mo brand-name cash reference.

Semaglutide
From $99/mo (starting dose, first-month rate, compounded)
Tirzepatide
Not disclosed
Coverage
All 50 states
Brand-name
Yes

The Value Score card

Maves scored on our six published factors. See the methodology.

Lowest Real Price90/100
No Teaser-Rate Bait64/100
Nationwide Availability96/100
Both Molecules70/100
Easy Cancellation58/100
Reputation87/100

Why it's a deal

  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer
  • $99/mo first-month intro pricing on semaglutide — among the most aggressive we track
  • All 50 states covered, stated explicitly
  • Both brand (Maves) and parent (Homera Health) disclosed for accountability

Read the fine print

  • 503A pharmacy partner not named (only 'licensed U.S. pharmacies')
  • Tirzepatide pricing not stated on the homepage — only listed as an offering
  • Named medical director / clinical leadership not disclosed
  • Refund and cancellation policy not detailed publicly
  • Corporate address and arbitration venue not disclosed

The bottom line

Best for: Shoppers who want $99 first-month semaglutide with men's-health and body-optimization framing. Maves, operating under parent company Homera Health, is a performance-framed telehealth platform offering compounded semaglutide and tirzepatide for weight loss plus sermorelin for anti-aging.

Ranked #74 of 427 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to Maves, out of 426 others we track.

Shopping Maves against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Maves, and every program that undercuts or outscores it — starting with Bliv, the closest match on score — is ranked on the Maves alternatives ranking.

More programs we track (24)

396 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from Maves's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Maves's site. Not medical advice; see our disclosure.

Where Maves ranks

See every program ranked by price →

← Back to all deals